Showing results (791-800 of 1,163) with videos related to

Sort By:
Pageof 117
European Journal of Heart Failure|July 30, 2024
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trialJasper Tromp, Carolyn S P Lam, Wendimagegn Alemayehu, et al.
JACC. Basic to Translational Science|December 14, 2023
The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEFCoenraad Withaar, Laura M G Meems, Edgar E Nollet, et al.
JAMA Network Open|June 1, 2019
Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS TrialAlexandra P Lam, Swantje Matthies, Erika Graf, et al.
Plos One|January 29, 2016
Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea CohortYa-Nan Zhang, Flora Vernooij, Irwani Ibrahim, et al.
ESC Heart Failure|September 30, 2021
Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotypeSarah Fitzsimons, Tee Joo Yeo, Lieng H Ling, et al.
European Journal of Heart Failure|March 11, 2015
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registryGerasimos Filippatos, Sadiya Sana Khan, Andrew P Ambrosy, et al.
Thorax|September 17, 2011
Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signallingGökhan M Mutlu, G R Scott Budinger, Minghua Wu, et al.
European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.
European Journal of Heart Failure|May 29, 2021
Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trialScott D Solomon, Rudolf A de Boer, David DeMets, et al.
European Journal of Heart Failure|March 3, 2022
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fractionClara Saldarriaga, Dan Atar, Amanda Stebbins, et al.
Pageof 117